The risk of infections with tumor necrosis factor-α inhibitors

Research output: Contribution to journalReview article

Abstract

Serious infections have an increased incidence of occurrence in those prescribed TNF- inhibitors. although the incidence rate of infections may be broadly interpreted as minimal, when compared with those prescribed high-dose glucocorticoids, a thorough work-up must be considered in the context of TNF blockade (Table 3). If infections are suspected, then treatment must be immediately initiated along with careful consideration for the continuation of TNF-inhibitor therapy. Prevention must always be the basis of any initial evaluation and all appropriate immunization strategies should be implemented.

Original languageEnglish (US)
Pages (from-to)419-426
Number of pages8
JournalJournal of Clinical Rheumatology
Volume15
Issue number8
DOIs
StatePublished - Dec 1 2009

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'The risk of infections with tumor necrosis factor-α inhibitors'. Together they form a unique fingerprint.

  • Cite this